Yahoo
    NasdaqCM - Nasdaq Real Time Price USD

    Genprex, Inc. (GNPX)

    2.0600 -0.0100 (-0.48%)
    At close: November 9 at 4:00:01 PM EST
    2.2404 +0.1804 (+8.76%)
    Pre-Market: 8:40:31 AM EST
    Loading Chart for GNPX
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    View More
    Genprex Presents Data Showing Reqorsa® Gene Therapy Activates Cellular Repair and Maintenance Programs Linked to Aging Biology in Patients, Supporting TUSC2 as a Key Regulator of Resilience to Aging-Associated Stress

    Genprex Presents Data Showing Reqorsa® Gene Therapy Activates Cellular Repair and Maintenance Programs Linked to Aging Biology in Patients, Supporting TUSC2 as a Key Regulator of Resilience to Aging-Associated Stress
    PR Newswire 5d ago
    Genprex Announces New Research Identifying TROP2 as a Potential Predictive Biomarker to Reqorsa® Gene Therapy in Lung Cancer

    Genprex Announces New Research Identifying TROP2 as a Potential Predictive Biomarker to Reqorsa® Gene Therapy in Lung Cancer
    PR Newswire 6d ago
    Genprex to Present TUSC2 Research from Sponsored Collaboration with Meharry Medical College at the Gerontological Society of America 2026 Annual Scientific Meeting

    Genprex to Present TUSC2 Research from Sponsored Collaboration with Meharry Medical College at the Gerontological Society of America 2026 Annual Scientific Meeting
    PR Newswire 13d ago
    Genprex Highlights New Preclinical Data Identifying Role of TUSC2, the Gene Used in REQORSA®, in Maintaining Cellular Function During Brain Aging

    Genprex Highlights New Preclinical Data Identifying Role of TUSC2, the Gene Used in REQORSA®, in Maintaining Cellular Function During Brain Aging
    PR Newswire 20d ago
    Genprex to Present at the H.C. Wainwright 28th Annual Global Investment Conference

    Genprex to Present at the H.C. Wainwright 28th Annual Global Investment Conference
    PR Newswire 2mo ago
    Andelyn Biosciences to Scale Manufacturing for Genprex's Diabetes Gene Therapy Program

    Andelyn Biosciences to Scale Manufacturing for Genprex's Diabetes Gene Therapy Program
    PR Newswire 2mo ago
    Genprex Selects Leading Clinical and Commercial Contract Development and Manufacturing Organization for Manufacturing Scale Up of Diabetes Gene Therapy

    Genprex Selects Leading Clinical and Commercial Contract Development and Manufacturing Organization for Manufacturing Scale Up of Diabetes Gene Therapy
    PR Newswire 2mo ago
    Genprex Shares Rise After Collaboration With Roche Diagnostics

    Genprex Shares Rise After Collaboration With Roche Diagnostics
    InvestorsHub 3mo ago
    Genprex Announces Collaboration with Roche Diagnostics for Biomarker Assay Validation Studies

    Genprex Announces Collaboration with Roche Diagnostics for Biomarker Assay Validation Studies
    PR Newswire 3mo ago
    Genprex’s Reqorsa combo secures Canadian patent for lung cancer

    Genprex’s Reqorsa combo secures Canadian patent for lung cancer
    Pharmaceutical Technology 4mo ago
    Genprex to Participate at BIO International Convention 2026

    Genprex to Participate at BIO International Convention 2026
    PR Newswire 4mo ago
    View More

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: